Response rate
| . | Arm A (n = 95) . | Arm B (n = 97) . | P . |
|---|---|---|---|
| CR and VGPR 3 mo after first transplantation | 38 (40) | 40 (41) | NS |
| PR 3 mo after first transplantation | 42 (44) | 41 (42) | NS |
| MR 3 mo after first transplantation | 9 (10) | 9 (10) | NS |
| PD 3 mo after first transplantation | 6 (6) | 7 (7) | NS |
| CR and VGPR | .04 | ||
| 6 mo after second transplantation | 50 (54) | NA | |
| 3 mo after maintenance thalidomide | NA | 66 (68) | |
| PR | NS | ||
| 6 mo after second transplantation | 36 (39) | NA | |
| 3 mo after maintenance thalidomide | NA | 26 (27) | |
| MR | NS | ||
| 6 mo after second transplantation | 3 (3) | NA | |
| 3 mo after maintenance thalidomide | NA | 3 (3) | |
| PD | NS | ||
| 6 mo after second transplantation | 4 (4) | NA | |
| 3 mo after maintenance thalidomide | NA | 2 (2) |
| . | Arm A (n = 95) . | Arm B (n = 97) . | P . |
|---|---|---|---|
| CR and VGPR 3 mo after first transplantation | 38 (40) | 40 (41) | NS |
| PR 3 mo after first transplantation | 42 (44) | 41 (42) | NS |
| MR 3 mo after first transplantation | 9 (10) | 9 (10) | NS |
| PD 3 mo after first transplantation | 6 (6) | 7 (7) | NS |
| CR and VGPR | .04 | ||
| 6 mo after second transplantation | 50 (54) | NA | |
| 3 mo after maintenance thalidomide | NA | 66 (68) | |
| PR | NS | ||
| 6 mo after second transplantation | 36 (39) | NA | |
| 3 mo after maintenance thalidomide | NA | 26 (27) | |
| MR | NS | ||
| 6 mo after second transplantation | 3 (3) | NA | |
| 3 mo after maintenance thalidomide | NA | 3 (3) | |
| PD | NS | ||
| 6 mo after second transplantation | 4 (4) | NA | |
| 3 mo after maintenance thalidomide | NA | 2 (2) |
Data are numbers (%). Response rate based on intention-to-treat analysis.
PD indicates progressive disease; NA, not applicable; and NS, not significant.